Question

A 61-year-old woman with T2DM and obesity (BMI 35) has ASCVD and CKD G3a (eGFR 52). A1C 7.8% on metformin. Which dual cardiorenal strategy is most consistent with guidelines?

Accepted Answer

Add SGLT2 inhibitor and/or GLP-1 RA with CV benefit regardless of A1C

Answer

Add SGLT2 inhibitor alone

Answer

Add GLP-1 RA alone

Answer

Add sulfonylurea then insulin

Answer

Avoid SGLT2 inhibitor due to CKD

Practice question

A 61-year-old woman with T2DM and obesity (BMI 35) has ASCVD and CKD G3a (eGFR 52). A1C 7.8% on metformin. Which dual cardiorenal strategy is most consistent with guidelines?